Embryonal Tumor with Multilayered Rosettes Overview
Learn About Embryonal Tumor with Multilayered Rosettes
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Paul Sondel is a Pediatric Hematologist Oncology provider in Madison, Wisconsin. Dr. Sondel is rated as an Elite provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Adult Soft Tissue Sarcoma, and Infantile Neutropenia.
Franco Locatelli practices in Rome, Italy. Mr. Locatelli is rated as an Elite expert by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Splenectomy.
Duke Children's Health Center Hematology/Oncology Clinic
Susan Kreissman is a Pediatrics provider in Durham, North Carolina. Dr. Kreissman has been practicing medicine for over 40 years and is rated as an Elite provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hepatoblastoma, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration.
Summary: The purpose of this study is to find out the genetic and biochemical makeup of your neuroblastic tumor, which influences its aggressiveness and the suitable therapy. These research studies include surface marker analysis, cytogenetics, cancer genes,genome sequencing, tumor growth-related genes and tumor growth in test tubes. Your blood, marrow, and hematopoietic stem cell samples will also be test...
Summary: This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy works for treating children with newly diagnosed high-risk neuroblastoma. Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found on the surface of neur...

